125,000 of that volume today was me with multiple limit purchase orders for 25,000 shares. More bullish than ever and now holding 500,000 shares. As I have discussed with several colleagues (two who are now investing), this upcoming clinical trial has the unique advantage of only having to demonstrate good efficacy as the safety has already been proven in eight clinical trials.